Skip to content
Facebook-f Twitter
KAOHOON INTERNATIONAL
  • Thailand
  • Asia
  • USA
  • World
  • |
  • Markets
  • Economics
  • Wealth
  • Technology
  • Politics
  • Opinion
  • Sustainability
Trending News
March 17, 2026
Betagro Establishes Four Subsidiaries to Support Overseas Expansion
March 17, 2026
Market Roundup 17 March 2026
March 17, 2026
Total Trading Value of Stocks and Bonds on 17 March 2026 by Investor Types
March 17, 2026
US Futures Slip after Gains as Oil and Fed Decision Remain in Focus
Home
/
MEDEZE
Posted 26/02/2026

Medeze Sets Sights on One-Billion-Baht Revenue in 2026, Driving Growth via ATMPs and Strategic Partnerships

Medeze Group Public Company Limited (SET: MEDEZE) has announced an ambitious roadmap for 2026,...

Posted 26/02/2026

MEDEZE Reports THB196 Million of Net Profit in 2025, Navigates Headwinds with Strategic Infra Investments for Future Growth

Medeze Group Public Company Limited (SET: MEDEZE) recently released its full-year 2025 financial results,...

Posted 13/02/2026

MEDEZE Showcases Global Regenerative Medicine Innovations at Lagos Conference

Dr. Veerapol Khemarangsan, Chief Executive Officer, and Mr. Piyawat Ratchapolsitte, Vice Chairman of the...

Posted 14/01/2026

Broker Bullish on MEDEZE’s ATMPs’ Growth for New S-Curve amid Franchise Expansion

Globex Securities projects a strong growth from Medeze Group Public Company Limited (SET: MEDEZE)...

Posted 14/01/2026

MEDEZE Targets THB1 Billion Revenue in 2026 on ATMPs and Stem Cell Innovations

Dr. Veerapol Khemarangsan, Managing Director of Medeze Group Public Company Limited (SET: MEDEZE), revealed...

Posted 23/12/2025

MEDEZE Targets 25% Growth for 2026, Emphasizes ATMP Innovation and Regional Expansion

Dr. Veerapol Khemarangsan, Chief Executive Officer of Medeze Group Public Company Limited (SET: MEDEZE),...

Posts navigation

1 2 … 6 Next Next

TOP NEWS OF THE WEEK

© KAOHOON. All Rights Reserved.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, it is assumed that you accept our Privacy policy.Accept and Close